go to contents

Akribes Biomedical GmbH

Back to list

Facts

Founded
Staff
5
Organization type
RDM medtech

Profile

Development of a new pharmacological treatment for chronic wounds, identified by implementation of the first assay platform for personalized medicine of chronic wounds. The proprietary assays combine diagnosis and therapy recommendations for individual chronic wound patients. A Ph1b/2a proof-of-concept study is planned for 2025.

Similar companies in RDM medtech

RobotDreams GmbH

Organization type
RDM medtech
Region
Styria
Cluster
Human.technology Styria
Details

sorbion Mayrhofer GmbH

Organization type
RDM medtech
Region
Lower Austria
Cluster
ecoplus
Topic
biological-derived devices
Details

PHOTONIC Optische Geräte GesmbH & Co KG.

Organization type
RDM medtech
Region
Vienna
Cluster
LISAvienna
Details

MediPrime GmbH

Organization type
RDM medtech
Region
Tyrol
Cluster
Life Sciences Tyrol
Topic
telemedicine and e-health
software for medicine
Details

Contact



Contact: